Filing Flows › Century Therapeutics (IPSC) › How it makes money
How Century Therapeutics (IPSC) makes money
Century Therapeutics (IPSC) made $109M of revenue in the first quarter 2025 (Q1 2025), up 128-fold from a year earlier. Of every dollar of revenue, 68¢ was left as operating profit, 70¢ was left as net earnings.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q1 2025 | % of revenue |
|---|---|---|
| Revenue | $109M | 100.0% |
| Operating profit | $74.2M | 67.9% |
| Net earnings | $76.6M | 70.1% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q1 2025 | $109M | 128× |
| Q4 2024 | $4.2M | 16× |
From Century Therapeutics' 10-Q filed May 15, 2025 (on EDGAR).
Questions
How does Century Therapeutics make money?
Century Therapeutics (IPSC) made $109M of revenue in the first quarter 2025 (Q1 2025), up 128-fold from a year earlier. Of every dollar of revenue, 68¢ was left as operating profit, 70¢ was left as net earnings.
What is Century Therapeutics' profit margin?
Net earnings were $76.6M, 70.1% of revenue, in the first quarter 2025; the operating margin was 67.9%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.